(¿Â¶óÀÎ) 2020³â ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦23Â÷ Çмú´ëȸ : 2020-11-27±³À°ÀÏÀÚ : 2020-11-27
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2020³â ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦23Â÷ Çмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ
´ã´çÀÚ : ÀÓº¸¶ó
¿¬¶ôó : 02-2019-3782
À̸ÞÀÏ :
kscm.office@gmail.com ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú¹Ì»ý¹°ÇÐ, ÀÇÇб³À°,
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 10 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 250,000¿ø
ºñ°í Àü¹®ÀÇ 60,000¿ø Àü°øÀÇ, º´¸®»ç, °£È£»ç ¹× Âü°¡ÀÚ 40,000¿ø ±âŸ(»ê¾÷°è) 250,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ 08:00~08:00 Registration ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ 09:00~09:10 Opening ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 09:10~09:35 Air and surface contamination of SARS-CoV-2 ±è¾îÁø(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 09:35~10:00 Duration of viable virus shedding for SARS-CoV-2 ±è¹Îö(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 10:00~10:25 Problem solving in SARS-CoV-2 molecular testing ¼ºÈï¼·(¿ï»êÀÇ´ë)
Åä·Ð 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 10:25~10:40 Discussion ()
ÈÞ½Ä 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 10:40~11:00 Coffee Break/On-line Poster & Exhibition ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 11:00~12:00 Oral Presentation I (English or Korean) ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 11:00~12:00 Oral Presentation II (Korean) ()
ÈÞ½Ä 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 12:00~13:30 Lunch/On-line Poster & Exhibition ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 13:30~13:55 Microbes and Alzheimer ±è»óÀ±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 13:30~13:55 CLSI update À¯Àοµ(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 13:55~14:20 Helicobacter pylori and gastric malignancies ÀÌÁØÇà(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 13:55~14:20 EUCAST update ±è´ë¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 14:20~14:45 Infection and myocardial infarction ±èÃæ±â(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 14:20~14:45 Manufacturer feedback on changing guidelines ¹ÚÁ¤¼ö(¼¿ïÀÇ´ë)
Åä·Ð 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A,B) 14:45~15:00 Discussion ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 15:00~15:40 CLSI Guidance for Susceptibility Testing of Infrequently Isolated Bacteria Sandra Richter(Biomerieux)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 15:40~16:10 One health-people, animals and the environment ÀåöÈÆ(ºÎ»êÀÇ´ë)
ÈÞ½Ä 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 16:10~16:30 Coffee Break/On-line Poster & Exhibition ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 16:30~16:55 Reorganization of legal communicable disease classification system ±Çµ¿Çõ(Áúº´°ü¸®Ã»)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 16:30~16:55 Laboratory considerations for the method diversity in IGRAs ±Ç¿ÀÁÖ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 16:55~17:20 Review guidelines for infectious disease ±è¿µ¾Æ(±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 16:55~17:20 Performance and Application of 16S rRNA Sequencing ¼ÛÁÖ¼±(GC³ì½ÊÀÚÁö³ð)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A) 17:20~17:45 Outbreak of hepatitis A virus ÇÑ¸í±¹(Áúº´°ü¸®Ã»)
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall B) 17:20~17:45 Recent Issues of Antimicrobial Resistance ±èµµ±Õ(¿¬¼¼ÀÇ´ë)
Åä·Ð 11¿ù 27ÀÏ ¿Â¶óÀÎ(Hall A,B) 17:45~18:00 Discussion ()
±³À°½Ã°£ 11¿ù 27ÀÏ ¿Â¶óÀÎ 18:00~18:30 Closing(ÃÑȸ, ½Ã»ó ¹× Æóȸ) ()